Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) will participate in two upcoming investor conferences. The William Blair 42nd Annual Growth Stock Conference takes place on June 8 at 3:20 p.m. CT in Chicago, IL, while the Goldman Sachs 43rd Annual Global Healthcare Conference is scheduled for June 15 at 10:00 a.m. PT in Rancho Palos Verdes, CA.

Live and archived webcasts will be accessible via their website.

SEATTLE, May 26, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.

• William Blair 42^nd Annual Growth Stock Conference in Chicago, IL
  Presenting on Wednesday, June 8^th at 3:20 p.m. Central Time

• Goldman Sachs 43^rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA
  Presenting on Wednesday, June 15^th at 10:00 a.m. Pacific Time

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics and drug discovery. We have three commercial products and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
Carrie Mendivil, Gilmartin Group
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Laura Cooper
205-908-5603
media@adaptivebiotech.com

FAQ

When is Adaptive Biotechnologies presenting at the William Blair conference?

Adaptive Biotechnologies will present at the William Blair 42nd Annual Growth Stock Conference on June 8 at 3:20 p.m. Central Time.

When is the Goldman Sachs conference for Adaptive Biotechnologies?

The Goldman Sachs 43rd Annual Global Healthcare Conference is set for June 15 at 10:00 a.m. Pacific Time.

Where can I watch the webcasts for Adaptive Biotechnologies' conference presentations?

Live and archived webcasts for Adaptive Biotechnologies' conference presentations can be found on their website in the Investors section.

What is the stock symbol for Adaptive Biotechnologies?

The stock symbol for Adaptive Biotechnologies is ADPT.